Delivery Order SPE2DB20D9329-SPE2DB22FZH98
Award Date 8/3/22
Potential Completion Date 8/4/22
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,123.76 contract is to provide a 4 mL solution of 4% Lidocaine HCl. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to supply a comprehensive range of branded and generic prescription drugs,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,461.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4558370572 - LIDOCAINE HCL 2% AMPUL 10ML, with a completion date of September 8, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,081.86, is for the delivery of Lidocaine Hydrochloride, a common local anesthetic. It is a firm fixed-price contract with an ultimate completion date of August 15, 2023. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
- The Defense Logistics Agency has awarded a delivery order valued at $2,545.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine HCL 2% in 25-subject packages. This firm fixed-price delivery order, issued on December 19, 2025, with an ultimate completion date of January 20, 2026, carries no set-aside designation, indicating that the vendor competed in an unrestricted procurement...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Lidocaine HCL 1% syringe 5ML. The one-year contract, with a potential value of $2,303.49, was awarded on January 25, 2024 and will run through January 26, 2024. This delivery order is likely part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at approximately $7,070 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The delivery order is for 4562524074 lidocaine hydrochloride to be supplied by DMS Pharmaceutical to the DLA for use by the Department of Defense. No subcontractors or set aside designations were identified. The delivery order has a period of performance from...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,088.99 contract is for the delivery of Lidocaine Ointment to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $1,307.37, is for the delivery of 4562017277 LIDOCAINE HYDROCHLORI and has an ultimate completion date of August 7, 2023. This award is not associated with a set-aside program. The contract is a delivery order under a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at forty-seven dollars to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The contract is for the delivery of fifty milliliter vials of one percent lidocaine hydrochloride to be completed by July 31, 2023 in support of the Agency's medical supply needs. No set-aside provisions were applied to this requirement. DMS Pharmaceutical Group Inc. will serve as the prime contractor responsible for fulfilling...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of fifty milliliter vials of 1% lidocaine hydrochloride. The contract has a potential value of forty-seven dollars and a completion date of July 31, 2023. No set-aside designation was used for this award to support the DLA's medical supply needs. DMS Pharmaceutical Group Inc. will deliver the requested pharmaceutical products from its location in Park Ridge, Illinois to an...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FZH98Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,107.48, is for the supply of 50ml vials of 1% lidocaine with 1:100,000 epinephrine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. The contract does not have a set-aside designation.
Generated 1/9/25, 9:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/3/22 |